Viewing StudyNCT00002369



Ignite Creation Date: 2024-05-05 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002369
Status: COMPLETED
Last Update Posted: 2007-10-02
First Post: 1999-11-02

Brief Title: A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb

Organization Data

Organization: Bristol-Myers Squibb
Class: INDUSTRY
Study ID: 260A
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Bristol-Myers Squibb
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators